Spruce Biosciences, Inc.
SPRBD
$8.20
-$0.30-3.53%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -86.43% | -71.27% | -51.32% | -1.40% | 131.82% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -86.43% | -71.27% | -51.32% | -1.40% | 131.82% |
Cost of Revenue | -8.21% | -3.71% | -7.48% | -25.00% | -0.36% |
Gross Profit | -14.65% | -14.34% | -3.76% | 29.26% | 14.59% |
SG&A Expenses | -3.66% | 3.43% | 15.76% | 10.11% | 12.51% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -8.93% | -1.03% | -1.64% | -16.29% | 3.81% |
Operating Income | -6.69% | -12.80% | -8.00% | 18.32% | 6.58% |
Income Before Tax | -12.13% | -18.61% | -10.68% | 19.72% | 10.49% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -12.13% | -18.61% | -10.68% | 19.72% | 10.49% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -12.13% | -18.61% | -10.68% | 19.72% | 10.49% |
EBIT | -6.69% | -12.80% | -8.00% | 18.32% | 6.58% |
EBITDA | -6.75% | -12.87% | -8.05% | 18.30% | 6.55% |
EPS Basic | -8.59% | -15.15% | -1.50% | 35.74% | 37.08% |
Normalized Basic EPS | -8.59% | -15.15% | -1.50% | 35.74% | 37.08% |
EPS Diluted | -8.59% | -15.15% | -1.50% | 35.74% | 37.08% |
Normalized Diluted EPS | -8.59% | -15.15% | -1.50% | 35.74% | 37.08% |
Average Basic Shares Outstanding | 4.47% | 2.92% | 7.22% | 20.20% | 36.95% |
Average Diluted Shares Outstanding | 4.47% | 2.92% | 7.22% | 20.20% | 36.95% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |